146 related articles for article (PubMed ID: 38189645)
21. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
[TBL] [Abstract][Full Text] [Related]
22. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
Tsai TH; Lee WY
Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
[TBL] [Abstract][Full Text] [Related]
23. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
[TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of SDHB, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study.
Karatay H; Ozluk Y; Dogan MA; Erdem S; Kilicaslan I
Ann Diagn Pathol; 2021 Oct; 54():151788. PubMed ID: 34246177
[TBL] [Abstract][Full Text] [Related]
25. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
Ozluk Y; Taheri D; Matoso A; Sanli O; Berker NK; Yakirevich E; Balasubramanian S; Ross JS; Ali SM; Netto GJ
Hum Pathol; 2015 Dec; 46(12):1951-5. PubMed ID: 26476567
[TBL] [Abstract][Full Text] [Related]
26. [Succinate dehydrogenase-deficient renal cell carcinoma:a clinicopathological, ultrastructural and molecular analysis].
Wang XT; Wang X; Zhang RS; Cheng K; Xia QY; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):12-16. PubMed ID: 34979747
[No Abstract] [Full Text] [Related]
27. Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.
CaliĆ³ A; Grignon DJ; Stohr BA; Williamson SR; Eble JN; Cheng L
Mod Pathol; 2017 Mar; 30(3):407-415. PubMed ID: 27910947
[TBL] [Abstract][Full Text] [Related]
28. Pink renal conundrum.
Sanders ML; Thomas DH; Varma M
J Clin Pathol; 2020 Sep; 73(9):610. PubMed ID: 32060077
[No Abstract] [Full Text] [Related]
29. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E
Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096
[TBL] [Abstract][Full Text] [Related]
30. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.
Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A
Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504
[TBL] [Abstract][Full Text] [Related]
31. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
[TBL] [Abstract][Full Text] [Related]
32. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
[TBL] [Abstract][Full Text] [Related]
33. Succinate Dehydrogenase Deficient Renal Cell Carcinoma With Sarcomatoid and Rhabdoid Features-A Diagnostic Dilemma.
Ajmal N; Lallas CD; McCue P; Li L
Int J Surg Pathol; 2024 Feb; ():10668969241229333. PubMed ID: 38311902
[TBL] [Abstract][Full Text] [Related]
34. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
35. Emerging Entities in Renal Neoplasia.
Mehra R; Smith SC; Divatia M; Amin MB
Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
[TBL] [Abstract][Full Text] [Related]
36. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
37. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
38. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
Miettinen M; Lasota J
Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
[TBL] [Abstract][Full Text] [Related]
39. cDNA microarray analysis assists in diagnosis of malignant intrarenal pheochromocytoma originally masquerading as a renal cell carcinoma.
Takahashi M; Yang XJ; McWhinney S; Sano N; Eng C; Kagawa S; Teh BT; Kanayama HO
J Med Genet; 2005 Aug; 42(8):e48. PubMed ID: 16061554
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]